Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Emerging Hydrogen Economy: Asia's Strategic Push Forward

Asia is making substantial strides toward establishing a strong hydrogen economy, with significant focus on its application in the transportation sector. Nations across the region are recognizing hydrogen’s potential to serve as a clean fuel alternative, and many are investing heavily to build related …

Vinay Lochav | 20 August 2026

China Expands Russian Crude Imports, Disrupting Indian Refining Sector

China's recent surge in imports of RussianCrude Oilhas significantly changed the dynamics within the global energy market, posing serious challenges for Indian refiners. As China increases its intake of this commodity, India's refiners face intensified competition, which could disrupt their market positions and profitability. …

Vinay Lochav | 20 August 2026

Orkla ASA (OTC: ORKLY) Q2 Revenue Climbs 9.9% to $7.14B, Exceeds Estimates

Orkla ASA (OTC: ORKLY), a prominent player in the packaged foods industry, reported a strong Q2 revenue figure of $7.14 billion, marking a 9.9% year-over-year increase. This figure exceeded the consensus expectations, showcasing the company's strong market position amidst growing demand for specialty and …

Vinay Lochav | 20 August 2026

Medtronic (NYSE: MDT) Eyes 50-Year Dividend Milestone After Latest Increase

With this increase, it is on the brink of becoming a Dividend King, having consistently raised its dividend for 49 consecutive years. This milestone underlines not only Medtronic (NYSE: MDT)’s commitment to returning value to shareholders but also positions it favorably among income-focused investors …

Vinay Lochav | 20 August 2026

Novo Nordisk's Low-Dose Wegovy Study Reflects Patient Cost Concerns

Novo Nordisk is testing lower doses of its obesity treatment Wegovy, aiming to identify the most effective dosing that also reduces costs and side effects. This study underscores the growingDemandfor weight loss solutions that patients can afford and tolerate, appealing to investors focused on …

Vinay Lochav | 20 August 2026

Cancer Vaccine Success Boosts Moderna and Merck Stocks

Moderna and Merck's collaboration on a personalized mRNA cancer vaccine has achieved promising results in late-stage trials, particularly for patients with melanoma. Evidence from the study indicates a significant extension in the time patients lived without experiencing cancer recurrence compared to existing treatments. This …

Vinay Lochav | 20 August 2026

Gubra A/S Highlights Strong H1 2026 Progress Amid Pipeline Advancements

Gubra A/S demonstrated substantial advancements in its pharmaceutical pipeline for H1 2026, showcasing its commitment to innovation and growth in the healthcare sector. The current trajectory not only reflects the company’s strategic planning but also its capability to navigate the complexities of drug development. …

Vinay Lochav | 20 August 2026

Melanoma Vaccine Trials Show Promise, Enhancing Investor Confidence

Merck and Moderna's melanomaVaccinetrial achieved significant progress, meeting primary and secondary endpoints for improved recurrence-free survival and distant metastasis-free survival. This breakthrough signals a potential shift in treatment approaches, presenting lucrativeInvestmentopportunities in next-generation cancer therapies.Key HighlightsThe trial's primary endpoint was successfully met, signaling improvements …

Vinay Lochav | 20 August 2026

IRIDEX Achieves Positive Cash Flow Driven by Glaucoma Sales Surge

IRIDEX Corporation has shifted into positive cash flow territory for the second quarter, marking a significant advancement following two years of intensive operational restructuring. This financial turnaround has been driven primarily by a 35% surge in sales of the Cyclo G6 probe, a key …

Vinay Lochav | 20 August 2026

Moderna Shares Surge 177% on Cancer Breakthrough, Then Drop 12%

Trial Success and Immediate Market Response

Vinay Lochav | 20 August 2026
Support

Hi! How can we help you today?

Loading…